Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort
Artículo

Open/ Download
Access note
Acceso a solo metadatos
Publication date
2020Metadata
Show full item record
Cómo citar
Quintana, Rosana
Cómo citar
Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort
Author
- Quintana, Rosana;
- Pons Estel, Guillermo J.;
- Roberts, Karen;
- Sacnun, Mónica;
- Serrano, Rosa;
- Nieto, Romina;
- Conti, Silvana;
- Gervasoni, Viviana;
- Catoggio, Luis J.;
- Soriano, Enrique R.;
- Scolnik, Marina;
- García, Mercedes A.;
- Alvarellos, Alejandro;
- Saurit, Verónica;
- Berbotto, Guillermo A.;
- Sato, Emilia;
- Lavras Costallat, Lilian T.;
- Borba Neto, Eduardo Ferreira;
- Bonfa, Eloisa;
- Xavier, Ricardo M.;
- de Oliveira e Silva Montandon, Ana Carolina;
- Molina Restrepo, José;
- Iglesias Gamarra, Antonio;
- Guibert Toledano, Marlene;
- Reyes Llerena, Gil Alberto;
- Massardo, Loreto;
- Neira Quiroga, Óscar;
- Cardiel, Mario H.;
- Barile Fabris, Leonor A.;
- Amigo, Mary-Carmen;
- Silveira, Luis H.;
- García de la Torre, Ignacio;
- Acevedo Vásquez, Eduardo;
- Ugarte Gil, Manuel;
- Alfaro Lozano, José Luis;
- Segami, María Inés;
- Chacón Díaz, Rosa;
- Esteva Spinetti, María H.;
- Gómez Puerta, José;
- Alarcón, Graciela;
- Pons Estel, Bernardo;
Abstract
Objectives This study aimed to compare the clinical features, damage accrual, and survival of patients with familial and sporadic systemic lupus erythematosus (SLE). Methods A multi-ethnic, multinational Latin American SLE cohort was studied. Familial lupus was defined as patients with a first-degree SLE relative; these relatives were interviewed in person or by telephone. Clinical variables, disease activity, damage, and mortality were compared. Odds ratios (OR) and 95% confidence intervals (CI) were estimated. Hazard ratios (HR) were calculated using Cox proportional hazard adjusted for potential confounders for time to damage and mortality. Results A total of 66 (5.6%) patients had familial lupus, and 1110 (94.4%) had sporadic lupus. Both groups were predominantly female, of comparable age, and of similar ethnic distribution. Discoid lupus (OR = 1.97; 95% CI 1.08-3.60) and neurologic disorder (OR = 1.65; 95% CI 1.00-2.73) were significantly associated with familial SLE; pericarditis was negatively associated (OR = 0.35; 95% CI 0.14-0.87). The SLE Disease Activity Index and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) were similar in both groups, although the neuropsychiatric (45.4% vs. 33.5%;p = 0.04) and musculoskeletal (6.1% vs. 1.9%;p = 0.02) domains of the SDI were more frequent in familial lupus. They were not retained in the Cox models (by domains). Familial lupus was not significantly associated with damage accrual (HR = 0.69; 95% CI 0.30-1.55) or mortality (HR = 1.23; 95% CI 0.26-4.81). Conclusion Familial SLE is not characterized by a more severe form of disease than sporadic lupus. We also observed that familial SLE has a higher frequency of discoid lupus and neurologic manifestations and a lower frequency of pericarditis.
Indexation
Artículo de publicación ISI Artículo de publicación SCOPUS
Quote Item
Lupus Jun 2020
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile
Related items
Showing items related by title, author, creator and subject.
-
Pons-Estel, Bernardo A.; Bonfa, Eloisa; Soriano, Enrique R.; Cardiel, Mario H.; Izcovich, Ariel; Popoff, Federico; Criniti, Juan M.; Vásquez, Gloria; Massardo, Loreto; Duarte, Margarita; Barile-Fabris, Leonor A.; García, Mercedes A.; Amigo, Mary Carmen; Espada, Gracie (BMJ Publishing Group, 2018)© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune ...
-
Reátegui-Sokolova, Cristina; Ugarte Gil, Manuel; Harvey, Guillermina B.; Wojdyla, Daniel; Pons Estel, Guillermo J.; Quintana, Rosana; Serrano Morales, Rosa M.; Sacnun, Mónica P.; Catoggio, Luis J.; Soriano, Enrique R.; García, Mercedes A.; Saurit, Verónica; Alvarellos, Alejandro; Caeiro, Francisco; Berbotto, Guillermo A.; Sato, Emilia I.; Borba Neto, Eduardo Ferreira; Bonfa, Eloisa; de Oliveira e Silva Montandon, Ana Carolina; Da Silva, Nilzio A; Cavalcanti, Fernando; Chacón Vásquez, Gloria; Guibert Toledano, Marlene; Reyes Llerena, Gil A.; Massardo, Loreto; Neira Quiroga, Óscar; Cardiel, Mario H.; Barile Fabris, Leonor A.; Amigo, Mary Carmen; Silveira, Luis H.; Portela-Hernández, Margarita; García de la Torre, Ignacio; Segami, María Inés; Chacón-Diaz, Rosa; Esteva Spinetti, María H.; Alarcón, Graciela S.; Pons-Estel, Bernardo A. (BMJ, 2020)Aim A decrease in proteinuria has been considered protective from renal damage in lupus nephritis (LN), but a cut-off point has yet to be established. The aim of this study was to identify the predictors of renal damage ...
-
Aguirre, Verónica; Alvo Abodovsky, Miriam; Ardiles, Leopoldo; Carpio, J. Daniel; Foster, Carolina; Goecke Sariego, Irmgadt; Jalil, Roberto; Massardo, Loreto; Palma, Sergio; Roessler, Emilio; Wurgaft, Andrés (Sociedad Medica de Santiago, 2015)© 2015, Sociedad Medica de Santiago. All rights reserved. Renal involvement affects over one half of patients with Systemic Lupus Erythematosus increasing their mortality and morbidity, including chronic renal disease and ...
Clinical-features.pdf (276.5Kb)